MORPHOLOGY AND PATHOLOGICAL SIGNIFICANCE OF FOCAL ACINAR CELL DYSPLASIA OF THE HUMAN PANCREAS

被引:7
作者
KISHI, K
NAKAMURA, K
YOSHIMORI, M
TAJIRI, H
OZAKI, H
KINOSHITA, T
KOSUGE, T
HAYAKAWA, M
机构
[1] Division of Clinical Pathology, Saitama Cancer Center Hospital
[2] Divisions of Medicine, National Cancer Center Hospital
[3] Divisions of Surgery, National Cancer Center Hospital
[4] Division of Clinical Laboratory, Yokufukai Hospital, Tokyo
关键词
PANCREAS; PRENEOPLASTIC LESION; ACINAR CELL DYSPLASIA;
D O I
10.1097/00006676-199203000-00008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Focal acinar cell dysplasia (FACD) was studied in 138 autopsied pancreases by multiple transsection examination and was found in 13 of the pancreases (9.4%). The average number of FACD per pancreas identified in our study was 5.7, ranging from 1 to 20, and the total number was 60. The location of FACD was 22 in head, 18 in body, and 20 in tail of the pancreas. FACD were rare lesions and found in only 41 of 2,819 slides (1.5%). The incidence of FACD seemed to be higher among males than among females, among patients with cancer in other sites than among those with no cancer, among diabetics than among nondiabetics, among heavy smokers than among nonsmokers, and among alcohol abusers than among abstainers. The males and heavy smokers had significantly more nodules of FACD per pancreas than females and nonsmokers. Simple and atypical hyperplasia of pancreatic ducts were found in 119 (86.2%) and 18 (13.0%), respectively. All pancreases with FACD had simple ductal hyperplasia. FACD and atypical ductal hyperplasia coexisted in one patient who had a history of heavy smoking, and this patient had the most nodules of FACD per pancreas among patients with FACD. No FACD was observed in pancreases without ductal hyperplasia. These findings suggested heavy cigarette smoking was one of the possible causes of FACD and ductal hyperplasia of pancreas.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 26 条
  • [1] Morris H.P., Wagner B.P., Ray F.E., Snell K.C., Stewart H.L., Comparative study of cancer and other lesions of rats fed N,N'-2,7-fluorenylenebisacetamide or N-2-fluorenylacet-amide, Natl Cancer Inst Monogr, 5, pp. 1-50, (1966)
  • [2] Hayashi Y., Furukawa H., Hasegawa T., Pancreatic tumors in rats induced by 4-nitroquinoline-l-oxide derivatives, Topics in Chemical Carcinogenesis, (1972)
  • [3] Longnecker D.S., Crawford B.G., Hyperplastic nodules and adenomas of exocrine pancreas in azaserine-treated rats, JNCI, 53, pp. 537-577, (1974)
  • [4] Konishi Y., Denta A., Inui S., Takahashi S., Kondo H., Pancreatic carcinoma induced by 4-hydroxyaminoquinoline-l-oxide after partial pancreatectomy and splenectomy in rats, Gann, 67, pp. 919-920, (1976)
  • [5] Longnecker D.S., Currphey T.J., Adenocarcinoma of the pancreas in azaserine-treated rats, Cancer Res, 35, pp. 2249-2256, (1975)
  • [6] Pour P., Runge R., Brit D., Et al., Current knowledge of pancreatic carcinogenesis in the hamster and its relevance to the human disease, Cancer, 47, pp. 1573-1587, (1981)
  • [7] Rao M.S., Subbarao V., Scarpelli D.S., Atypical acinar cell lesions of the pancreas in mice induced by 4-hydroxyamino-quinoline-l-oxide, Int J Pancreatology, 2, pp. 1-9, (1989)
  • [8] Rowlatt U., Roe E.T., Epithelial tumors of the rat pancreas, JNCI, 39, pp. 17-32, (1967)
  • [9] Hickel P., Nordmann J., Les adenomes solides du pancreas a disposition exocrine, Bull Soc Anat, 93, pp. 187-190, (1923)
  • [10] Glenner G.G., Mallory G.K., The cystadenoma and related nonfunctional tumors of the pancreas, Cancer, 9, pp. 980-996, (1956)